Prognostic implications of calculated Apo‐lipoprotein B in patients with ST‐segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcome is tied to lower cut‐points

BACKGROUND: Debates still surround using lipoproteins including Apo‐B in risk assessment, management, and prognosis of patients with coronary artery disease. During an acute ST‐segment elevation myocardial infarction, Apo‐B might help to achieve incremental prognostic information. OBJECTIVE: We soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghodsi, Saeed, Mohebi, Mehrnaz, Sadre‐Bafghi, Seyed‐Ali, Poorhosseini, Hamidreza, Salarifar, Mojtaba, Alidoosti, Mohammad, Haji‐Zeinali, Ali‐Mohammad, Amirzadegan, Alireza, Aghajani, Hassan, Jenab, Yaser, Hosseini, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207970/
https://www.ncbi.nlm.nih.gov/pubmed/33942349
http://dx.doi.org/10.1002/clc.23610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207970/
https://www.ncbi.nlm.nih.gov/pubmed/33942349
http://dx.doi.org/10.1002/clc.23610

Ejemplares similares